Free Trial

Veradigm (NASDAQ:MDRX) Shares Cross Above Two Hundred Day Moving Average - Here's Why

Veradigm logo with Business Services background

Key Points

  • Veradigm Inc. shares have crossed above their 200-day moving average, rising to a high of $4.75 before last trading at $4.25.
  • The company's 50-day moving average is currently at $4.74, indicating a recent decline of 9.6% in the stock price.
  • Veradigm is a healthcare technology company that offers a range of IT solutions to healthcare organizations, including electronic health records and analytics.
  • MarketBeat previews the top five stocks to own by October 1st.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.54 and traded as high as $4.75. Veradigm shares last traded at $4.25, with a volume of 10,211 shares.

Veradigm Trading Down 9.6%

The stock's 50-day moving average is $4.74 and its 200-day moving average is $4.54.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.